{"gene":"XRCC4","run_date":"2026-04-28T23:00:23","timeline":{"discoveries":[{"year":1995,"finding":"XRCC4 encodes a novel nuclear protein required for completion of V(D)J recombination (both coding and signal joints) and DNA double-strand break repair, as demonstrated by functional complementation of XRCC4-deleted XR-1 CHO cells.","method":"cDNA cloning, functional complementation of mutant cell line, V(D)J recombination assay","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — clean KO complementation with defined cellular phenotype, foundational paper","pmids":["8548796"],"is_preprint":false},{"year":1997,"finding":"XRCC4 directly interacts with DNA ligase IV and stimulates its ligation activity 5–8 fold, establishing that XRCC4's biological function is primarily to potentiate DNA ligase IV for double-strand break ligation and V(D)J recombination.","method":"Co-immunoprecipitation, yeast two-hybrid, in vitro ligation assay with purified recombinant proteins","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with purified proteins plus co-IP, replicated by multiple labs","pmids":["9242410"],"is_preprint":false},{"year":1997,"finding":"XRCC4 interacts with DNA ligase IV via the ligase IV carboxy-terminal extension containing tandem BRCT motifs, and XRCC4 is a nuclear phosphoprotein that serves as an efficient substrate for DNA-PK in vitro.","method":"Co-immunoprecipitation, co-purification over multiple chromatographic steps, adenylylation assay, in vitro kinase assay","journal":"Current Biology","confidence":"High","confidence_rationale":"Tier 1–2 — reciprocal co-IP plus biochemical co-purification and functional assay","pmids":["9259561"],"is_preprint":false},{"year":1997,"finding":"XRCC4 forms a homodimer in vivo with the dimerization domain mapping to amino acids 115–204, and the core domain required for V(D)J recombination comprises amino acids 18–204.","method":"Yeast two-hybrid, deletion mutagenesis, transient V(D)J recombination assay","journal":"International Immunology","confidence":"Medium","confidence_rationale":"Tier 2 — deletion mapping combined with functional assay, single lab","pmids":["9352367"],"is_preprint":false},{"year":1998,"finding":"DNA ligase IV binds XRCC4 via a region located between (not within) its two BRCT domains; this inter-BRCT linker region is necessary and sufficient for XRCC4 binding.","method":"Deletion analysis of ligase IV, co-immunoprecipitation","journal":"Current Biology","confidence":"High","confidence_rationale":"Tier 2 — systematic deletion mapping with co-IP, mechanistically precise","pmids":["9705934"],"is_preprint":false},{"year":1998,"finding":"XRCC4 is phosphorylated in vitro by DNA-PK (and an unidentified kinase) on serine/threonine residues within its C-terminal 130 amino acids, and XRCC4 facilitates Ku binding to DNA, promoting DNA-PK complex assembly.","method":"In vitro kinase assay with recombinant proteins, Sf9 insect-cell expression, DNA-binding assay","journal":"Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro assay with purified proteins, single lab","pmids":["9430729"],"is_preprint":false},{"year":1998,"finding":"The yeast XRCC4 ortholog LIF1 interacts with the C-terminal BRCT domain of yeast Lig4, occurs as a Lig4-LIF1 heterodimer in vivo, stabilizes Lig4, and is required for non-homologous end joining; LIF1 disruption phenocopies lig4 mutants.","method":"Yeast two-hybrid, gene disruption, plasmid end-joining assay, Western blot for protein stability","journal":"EMBO Journal","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods in yeast ortholog, replicated concept","pmids":["9670033"],"is_preprint":false},{"year":1999,"finding":"XRCC4 is required to stabilize DNA ligase IV protein (not mRNA) in cells; in XRCC4-deficient XR-1 cells, ligase IV protein is nearly undetectable, and reintroduction of XRCC4 restores ligase IV to wild-type levels.","method":"Western blot for protein levels, Northern blot for mRNA, complementation of XR-1 cells","journal":"Mutation Research","confidence":"High","confidence_rationale":"Tier 2 — complementation experiment with protein and mRNA analysis, replicated concept","pmids":["10047779"],"is_preprint":false},{"year":1999,"finding":"XRCC4 binds DNA with preference for nicked or broken ends; the DNA-binding activity correlates with complementation of V(D)J recombination defects but is not required for stimulation of DNA ligase IV adenylation.","method":"DNA-binding assay, in vitro ligation assay, complementation of XRCC4-deficient cells","journal":"EMBO Journal","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro biochemical assays plus cellular complementation, separation of function","pmids":["10202163"],"is_preprint":false},{"year":2000,"finding":"XRCC4 crystal structure reveals an elongated dumbbell-shaped tetramer with an N-terminal globular head containing a putative DNA-binding HTH motif and a long C-terminal coiled-coil stalk that mediates ligase IV interaction and tetramerization.","method":"X-ray crystallography at 2.7 Å resolution","journal":"EMBO Journal","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with functional domain interpretation","pmids":["11080143"],"is_preprint":false},{"year":2000,"finding":"The XRCC4-ligase IV complex directly binds Ku at DNA ends; Ku is required to recruit XRCC4-ligase IV to DNA ends, and this recruitment stimulates the initial ligation rate 20-fold in vitro.","method":"Direct protein-protein interaction assay, in vitro ligation assay, DNA-binding assay","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro reconstitution with purified proteins, quantitative kinetics","pmids":["10757784"],"is_preprint":false},{"year":2000,"finding":"DNA ligase IV-XRCC4 complex binds specifically to DNA ends and can act as a bridging factor linking DNA molecules; DNA-PKcs (but not Ku alone) stimulates intermolecular ligation by the complex.","method":"In vitro ligation assay, DNA end-binding assay, protein-protein interaction at DNA ends","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with multiple purified components","pmids":["10854421"],"is_preprint":false},{"year":2000,"finding":"p53 deficiency rescues embryonic lethality and neuronal apoptosis caused by XRCC4 deficiency in mice, placing XRCC4 upstream of p53-dependent apoptosis; XRCC4-null/p53-null mice develop pro-B-cell lymphomas with IgH-c-myc translocations.","method":"Genetic epistasis in double-knockout mice, tumor analysis, cytogenetics","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis in mouse model with defined phenotypic readout","pmids":["10786799"],"is_preprint":false},{"year":2001,"finding":"Crystal structure of XRCC4 bound to the inter-BRCT linker peptide of DNA ligase IV reveals that one ligase chain binds asymmetrically to an XRCC4 dimer; XRCC4 helical tails form a coiled-coil that unwinds upon ligase binding, creating a flat interaction surface stabilized by charged hydrogen bonds and hydrophobic contacts.","method":"X-ray crystallography","journal":"Nature Structural Biology","confidence":"High","confidence_rationale":"Tier 1 — crystal structure of the complex","pmids":["11702069"],"is_preprint":false},{"year":2003,"finding":"DNA-PK phosphorylates XRCC4 at serines 260 and 318 in the C-terminal region in vitro, but substitution of all phosphorylation sites to alanine does not impair cell survival after ionizing radiation or V(D)J recombination.","method":"Mass spectrometry mapping, site-directed mutagenesis, clonogenic survival assay, V(D)J recombination assay","journal":"DNA Repair","confidence":"High","confidence_rationale":"Tier 1–2 — MS-based site mapping combined with mutagenesis and functional cellular assays","pmids":["14599745"],"is_preprint":false},{"year":2003,"finding":"XRCC4 dimer binds DNA ligase IV in a 2:1 stoichiometry in solution; tetramerization of XRCC4 and DNA ligase IV binding are mutually exclusive because they share overlapping interfaces.","method":"Equilibrium sedimentation, mutational analysis, size-exclusion chromatography","journal":"Journal of Molecular Biology","confidence":"High","confidence_rationale":"Tier 1–2 — biophysical analysis with mutagenesis defining stoichiometry and mutual exclusivity","pmids":["14607114"],"is_preprint":false},{"year":2004,"finding":"XRCC4 physically links polynucleotide kinase (PNK) to DNA ligase IV: CK2-phosphorylated XRCC4 is recognized by the FHA domain of PNK, and disruption of this interaction in vivo increases radiosensitivity and slows DSB repair kinetics.","method":"Co-immunoprecipitation, phosphopeptide binding, in vitro end-joining assay, cellular repair kinetics","journal":"EMBO Journal","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including in vitro and cellular assays","pmids":["15385968"],"is_preprint":false},{"year":2004,"finding":"DSB induction causes DNA-PK-dependent phosphorylation and mobilization of XRCC4-ligase IV from the soluble nucleoplasm to a less-extractable nuclear fraction; DNA-PKcs is required for XRCC4-ligase IV complex recruitment, and ligase IV is needed for stable XRCC4 recruitment.","method":"Biochemical fractionation, co-immunoprecipitation, siRNA knockdown in human cells, laser-induced DSBs","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 — fractionation with functional requirements established by dependency experiments","pmids":["15520013"],"is_preprint":false},{"year":2006,"finding":"XRCC4 is SUMOylated at lysine 210; this modification is required for nuclear localization of XRCC4, and a SUMOylation-deficient mutant remains cytoplasmic, causes radiation sensitivity, and fails to support V(D)J recombination.","method":"In vitro and in vivo SUMOylation assay, site-directed mutagenesis, subcellular fractionation, clonogenic survival, V(D)J assay","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 1–2 — PTM mapping with mutagenesis and functional cellular readouts","pmids":["16478998"],"is_preprint":false},{"year":2006,"finding":"XLF (XRCC4-like factor/Cernunnos) directly interacts with the XRCC4-ligase IV complex in vitro and in vivo; siRNA depletion of XLF causes radiosensitivity and impaired NHEJ, identifying XLF as a core NHEJ component.","method":"Co-immunoprecipitation, in vitro pulldown, siRNA knockdown, clonogenic survival, NHEJ assay","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP plus in vitro interaction plus functional cellular assays, replicated","pmids":["16439205"],"is_preprint":false},{"year":2006,"finding":"Cernunnos/XLF physically interacts with the XRCC4-ligase IV complex and is the human homolog of yeast Nej1, connecting the NHEJ ligation complex across eukaryotes.","method":"Co-immunoprecipitation, sequence analysis, structural prediction","journal":"Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 3 — single co-IP plus computational analysis","pmids":["16571728"],"is_preprint":false},{"year":2006,"finding":"XRCC4 directly interacts with Ku70, and XRCC4-ligase IV accumulation at DSBs depends on Ku70/80 but not DNA-PKcs, suggesting Ku serves as a flexible tether between Ku70/80 and ligase IV via XRCC4.","method":"Pulsed near-IR laser DSB induction, live-cell imaging (FRAP), direct protein-protein interaction assay","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 — direct interaction assay combined with live-cell imaging and kinetic analysis","pmids":["17124166"],"is_preprint":false},{"year":2007,"finding":"XRCC4:DNA ligase IV can ligate two DNA ends with fully incompatible 3' overhangs (no base pairing) and can ligate across 1 nt gaps; this intrinsic flexibility of the complex explains in vivo end-joining at mismatched ends.","method":"In vitro ligation assay with defined incompatible DNA substrates, purified human XRCC4:Lig4","journal":"EMBO Journal","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with defined substrates and purified proteins","pmids":["17290226"],"is_preprint":false},{"year":2007,"finding":"XRCC4 plays a role in immunoglobulin class switch recombination (CSR); B-lymphocyte-specific conditional XRCC4 knockout reduces CSR approximately 2-fold in vivo and in vitro.","method":"Conditional knockout mouse (loxP/Cre), in vivo and in vitro CSR assay","journal":"Journal of Experimental Medicine","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with defined cellular phenotype","pmids":["17606631"],"is_preprint":false},{"year":2007,"finding":"Ku interacts with DNA ligase IV via the first BRCT motif of ligase IV; this interaction is enhanced by XRCC4 and dsDNA; DNA-PK kinase activity causes disassembly of the Ku/DNA ligase IV/XRCC4 complex.","method":"Pulldown assay, deletion mapping, in vitro kinase assay","journal":"DNA Repair","confidence":"Medium","confidence_rationale":"Tier 2–3 — pulldown with deletion mapping, single lab","pmids":["17241822"],"is_preprint":false},{"year":2008,"finding":"XLF promotes re-adenylation of the ligase IV-XRCC4 complex after ligation, allowing in situ recharging of ligase IV to facilitate double-strand ligation by a single complex; XLF is a weakly bound partner of the tight LX complex.","method":"Biochemical adenylation assay, in vitro ligation assay, cellular DSB repair kinetics","journal":"Nucleic Acids Research","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro biochemical dissection of mechanism combined with cellular assays","pmids":["19056826"],"is_preprint":false},{"year":2008,"finding":"Werner protein (WRN) physically interacts with the XRCC4-DNA ligase IV complex; this interaction stimulates WRN exonuclease (but not helicase) activity, and WRN-processed substrates are subsequently ligated by XRCC4-ligase IV, coordinating end processing with ligation.","method":"Co-immunoprecipitation, in vitro exonuclease assay, in vitro ligation assay","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP plus in vitro functional assay, single lab","pmids":["18558713"],"is_preprint":false},{"year":2009,"finding":"High-resolution crystal structure of human XRCC4 bound to the tandem BRCT repeat of DNA ligase IV reveals an extensive binding interface formed by a helix-loop-helix in the inter-BRCT linker plus significant contacts from the second BRCT domain, inducing a kink in the XRCC4 tail; interaction with the second BRCT domain is necessary for stable binding in cells.","method":"X-ray crystallography, cellular complementation, dominant-negative overexpression","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 1 — crystal structure plus cellular functional validation","pmids":["19332554"],"is_preprint":false},{"year":2010,"finding":"Unphosphorylated XRCC4 interacts with the catalytic domain of PNKP (stimulating PNKP turnover), while CK2-phosphorylated XRCC4 binds the PNKP FHA domain with high affinity but inhibits PNKP activity; the XRCC4-ligase IV complex also stimulates PNKP turnover independently of XRCC4 phosphorylation.","method":"In vitro kinase assay, pulldown/co-IP, in vitro PNKP activity assay","journal":"Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple in vitro assays, single lab","pmids":["20852255"],"is_preprint":false},{"year":2010,"finding":"DNA ligase IV controls nuclear localization and stability of XRCC4: in ligase IV-deficient cells, XRCC4 remains cytoplasmic even after DSB induction; ligase IV also regulates nuclear import of XLF.","method":"Subcellular fractionation, immunofluorescence, Western blot in ligase IV-deficient cells","journal":"DNA Repair","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization experiment with functional consequence, single lab","pmids":["24984242"],"is_preprint":false},{"year":2011,"finding":"XRCC4 and XLF form alternating parallel super-helical filaments via head-domain interactions (XLF Leu-115 'Leu-lock' inserts into a hydrophobic XRCC4 pocket); these filaments form a positively charged DNA-binding channel that aligns ends for ligation.","method":"X-ray crystallography, SAXS, site-directed mutagenesis, biophysical analysis","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structure combined with mutagenesis and SAXS, multiple orthogonal methods","pmids":["21775435"],"is_preprint":false},{"year":2011,"finding":"Crystal structure of XLF-XRCC4 complex at 3.94 Å confirms filament arrangement; four XRCC4 residues (Glu55, Asp58, Met61, Phe106) are essential for XLF interaction as determined by mutagenesis and calorimetry.","method":"X-ray crystallography, electron microscopy, site-directed mutagenesis, isothermal titration calorimetry","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 1 — crystal structure combined with mutagenesis and calorimetric validation","pmids":["21768349"],"is_preprint":false},{"year":2011,"finding":"XRCC4 controls nuclear import and sub-nuclear distribution of DNA ligase IV; when co-expressed with XRCC4, ligase IV is efficiently imported and distributes like XRCC4; the XRCC4-ligase IV complex exchanges faster at DNA damage sites than XRCC4 alone.","method":"Fluorescent fusion protein expression, live-cell imaging, FRAP, nuclear fractionation","journal":"DNA Repair","confidence":"Medium","confidence_rationale":"Tier 2 — direct live-cell imaging with functional consequence, single lab","pmids":["21982441"],"is_preprint":false},{"year":2012,"finding":"XRCC4-XLF complexes robustly bridge two independent DNA molecules; this bridging activity is DNA ligase IV-independent and suggests an early role for the complex in holding broken DNA ends together prior to ligation.","method":"DNA bridging assay, direct visualization, crystal structure at 3.94 Å, mutational analysis","journal":"Nucleic Acids Research","confidence":"High","confidence_rationale":"Tier 1–2 — biochemical bridging assays combined with crystal structure and mutagenesis","pmids":["22287571"],"is_preprint":false},{"year":2014,"finding":"XRCC4 undergoes M-phase-specific phosphorylation requiring CDK activity and Plk1; a phosphorylation-defective XRCC4 mutant shows more efficient M-phase DSB repair but increased anaphase bridge formation, indicating this phosphorylation suppresses NHEJ during mitosis to prevent genomic instability.","method":"Site-directed mutagenesis, kinase inhibition, live-cell imaging, chromosome analysis","journal":"PLOS Genetics","confidence":"Medium","confidence_rationale":"Tier 2 — mutagenesis with cellular phenotype, single lab","pmids":["25166505"],"is_preprint":false},{"year":2015,"finding":"FBXW7-mediated K63-linked polyubiquitylation of XRCC4 at lysine 296 (triggered by DNA-PKcs phosphorylation of XRCC4 at Ser325/326 after IR and ATM phosphorylation of FBXW7 at Ser26) enhances XRCC4 association with Ku70/80 to facilitate NHEJ.","method":"Co-immunoprecipitation, mass spectrometry, site-directed mutagenesis, in vivo ubiquitylation assay, clonogenic survival","journal":"Molecular Cell","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods identifying PTM writer (SCF-FBXW7), modification site, and functional consequence","pmids":["26774286"],"is_preprint":false},{"year":2015,"finding":"PAXX (paralog of XRCC4 and XLF) has a crystal structure resembling XRCC4, directly interacts with Ku (not XRCC4 directly), and is recruited to DSB sites; PAXX promotes Ku-dependent DNA ligation in vitro and functions together with XRCC4 and XLF in NHEJ.","method":"X-ray crystallography, co-immunoprecipitation, CRISPR-Cas9 knockout, in vitro ligation assay, chromatin fractionation","journal":"Science","confidence":"High","confidence_rationale":"Tier 1–2 — crystal structure combined with genetic KO and in vitro reconstitution","pmids":["25574025"],"is_preprint":false},{"year":2015,"finding":"CK2-phosphorylated XRCC4 is recognized by the FHA domain of APLF; crystal structure of the phospho-XRCC4-APLF complex reveals the binding mode and shows distinct but overlapping specificities among FHA domain family members for XRCC4 vs. XRCC1 scaffolds.","method":"X-ray crystallography, NMR, biochemical binding assays","journal":"DNA Repair","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with NMR and biochemical validation","pmids":["26519825"],"is_preprint":false},{"year":2016,"finding":"XRCC4-XLF complexes form mobile sleeve-like structures that can slide along DNA and bridge two independent DNA molecules; XLF stimulates XRCC4 binding to DNA, and the resulting heteromeric complexes diffuse swiftly along DNA, enabling rapid reconnection of broken ends.","method":"Dual- and quadruple-trap optical tweezers with fluorescence microscopy (single-molecule)","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — single-molecule biophysical reconstitution with direct real-time observation","pmids":["27437582"],"is_preprint":false},{"year":2017,"finding":"Phospho-mimicking mutations in the C-terminal tails of both XRCC4 and XLF reduce stability and DNA-bridging capacity of XRCC4/XLF filaments without affecting their ability to stimulate ligase IV activity, indicating that DNA-PK/ATM phosphorylation of these tails specifically regulates DNA bridging.","method":"Site-directed mutagenesis (14 phosphorylation sites), in vitro DNA bridging assay, ligation stimulation assay","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1–2 — systematic mutagenesis with separation-of-function between bridging and ligation stimulation","pmids":["28500754"],"is_preprint":false},{"year":2017,"finding":"XRCC4-ligase IV complex stimulates Artemis endonuclease activity on 3' overhangs in a DNA-PKcs-independent manner; X4-LIV and DNA-PKcs interfere with each other in stimulating Artemis, supporting sequential rather than concurrent recruitment.","method":"In vitro nuclease assay, in vitro ligation assay with defined DNA substrates","journal":"Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro reconstitution, single lab","pmids":["28696258"],"is_preprint":false},{"year":2017,"finding":"The PNKP-XRCC4-LigIV complex requires XRCC4 phosphorylation for stable PNKP binding (one PNKP per XRCC4 dimer); SAXS and hydrogen-deuterium exchange reveal that PNKP makes multipoint contacts with XRCC4 coiled-coil and LigIV BRCT repeats; a disease mutation E326K on the PNKP phosphatase domain surface impairs PNKP recruitment to DSBs.","method":"SAXS, HDX-MS, in vitro complex reconstitution, site-directed mutagenesis, cellular recruitment assay","journal":"Nucleic Acids Research","confidence":"High","confidence_rationale":"Tier 1 — reconstituted complex characterized by multiple structural and biochemical methods","pmids":["28453785"],"is_preprint":false},{"year":2021,"finding":"RIG-I interacts with XRCC4 and the RIG-I/XRCC4 interaction impedes formation of the XRCC4/LIG4/XLF complex at DSBs, suppressing NHEJ; reciprocally, XRCC4 promotes RIG-I immune signaling by enhancing RIG-I oligomerization and ubiquitination.","method":"Co-immunoprecipitation, DSB recruitment assay, in vitro ligation assay, RNA virus replication assay, mouse model","journal":"Nature Communications","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP plus functional in vitro and in vivo assays, single lab","pmids":["33846346"],"is_preprint":false}],"current_model":"XRCC4 is a dimeric scaffold protein that forms a tight constitutive complex with DNA ligase IV (via the inter-BRCT linker of ligase IV binding to the XRCC4 coiled-coil), stabilizing ligase IV and stimulating its adenylation and ligation activity; after DSB induction, Ku70/80 (which directly contacts XRCC4) recruits the XRCC4-ligase IV complex to DNA ends where XRCC4 also scaffolds PNK/PNKP (via CK2-phosphorylated XRCC4 recognized by the PNKP FHA domain) to coordinate end processing with ligation; XRCC4 additionally co-assembles with XLF into dynamic, sliding filaments that bridge and align broken DNA ends, an activity regulated by DNA-PK/ATM phosphorylation of their C-terminal tails, while nuclear localization of XRCC4 itself depends on SUMOylation at K210 and on its interaction with ligase IV."},"narrative":{"teleology":[{"year":1995,"claim":"Identifying XRCC4 as a gene required for both V(D)J recombination and DSB repair established that a previously unknown nuclear factor was essential for the final joining step of NHEJ.","evidence":"cDNA cloning and functional complementation of the XRCC4-deficient XR-1 CHO cell line","pmids":["8548796"],"confidence":"High","gaps":["No binding partners or biochemical activity identified","Mechanism of action unknown"]},{"year":1997,"claim":"Discovery that XRCC4 directly binds and stimulates DNA ligase IV, and that their interaction maps to the ligase IV C-terminal BRCT region, defined XRCC4's primary molecular role as a ligase IV cofactor.","evidence":"Co-IP, yeast two-hybrid, and in vitro ligation assays with purified recombinant proteins; co-purification and adenylation assays","pmids":["9242410","9259561","9352367"],"confidence":"High","gaps":["Precise binding interface not resolved","Stoichiometry uncertain","How the complex is recruited to DSBs unknown"]},{"year":1998,"claim":"Mapping the ligase IV binding site to the inter-BRCT linker (not the BRCT domains themselves) and showing XRCC4 is a DNA-PK substrate placed XRCC4 in a regulated signaling context at DSBs.","evidence":"Systematic deletion analysis with co-IP; in vitro kinase assay with purified DNA-PK; yeast ortholog LIF1 disruption phenocopying lig4 mutants","pmids":["9705934","9430729","9670033"],"confidence":"High","gaps":["Functional consequence of DNA-PK phosphorylation unknown","In vivo recruitment mechanism unresolved"]},{"year":1999,"claim":"Demonstrating that XRCC4 stabilizes ligase IV at the protein level and that XRCC4 binds DNA with preference for nicked/broken ends separated its stabilization function from its DNA-end recognition activity.","evidence":"Western/Northern blot in XR-1 cells with XRCC4 complementation; DNA-binding assays and in vitro ligation with separation-of-function mutants","pmids":["10047779","10202163"],"confidence":"High","gaps":["DNA-binding surface not structurally defined","How DNA binding contributes to in vivo repair unclear"]},{"year":2000,"claim":"Crystal structure of XRCC4, combined with reconstitution of Ku-dependent end recruitment and DNA bridging by XRCC4–ligase IV, established the architectural framework of the NHEJ ligation complex and showed that Ku is the DNA-end recruiter.","evidence":"X-ray crystallography at 2.7 Å; in vitro reconstitution with Ku and DNA-PKcs showing 20-fold ligation stimulation; genetic epistasis in XRCC4/p53 double-KO mice","pmids":["11080143","10757784","10854421","10786799"],"confidence":"High","gaps":["Structure of the XRCC4–ligase IV complex not yet solved","Stoichiometry in vivo debated (tetramer vs. dimer)"]},{"year":2001,"claim":"The crystal structure of the XRCC4–ligase IV inter-BRCT linker complex revealed how one ligase IV chain binds asymmetrically to the XRCC4 dimer, unwinding the coiled-coil to create a flat interface — resolving the binding mode.","evidence":"X-ray crystallography of the binary complex","pmids":["11702069"],"confidence":"High","gaps":["Role of BRCT2 contacts not captured at this resolution","How tetramerization and ligase IV binding are regulated not clear"]},{"year":2003,"claim":"Establishing 2:1 XRCC4 dimer:ligase IV stoichiometry and mutual exclusivity with tetramerization resolved a structural ambiguity, while showing that DNA-PK phosphorylation sites on XRCC4 are dispensable for survival and V(D)J recombination raised the question of what these modifications do.","evidence":"Equilibrium sedimentation and size-exclusion chromatography; mass spectrometry phosphosite mapping with alanine mutagenesis and functional assays","pmids":["14607114","14599745"],"confidence":"High","gaps":["Functional role of DNA-PK phosphorylation on XRCC4 unresolved","Whether tetramer has any physiological role unclear"]},{"year":2004,"claim":"Identification of CK2-phosphorylated XRCC4 as the bridge linking PNKP to the ligation complex, and demonstration that DNA-PKcs drives XRCC4–ligase IV mobilization to DSBs, established XRCC4 as an actively regulated scaffold coupling end-processing with ligation.","evidence":"Co-IP, phosphopeptide binding with FHA domain, cellular repair kinetics; biochemical fractionation with siRNA knockdown","pmids":["15385968","15520013"],"confidence":"High","gaps":["Structural basis of CK2-phospho-XRCC4/PNKP FHA interaction not visualized","Temporal ordering of CK2 vs. DNA-PK phosphorylation events unclear"]},{"year":2006,"claim":"Discovery that SUMOylation at K210 is required for XRCC4 nuclear localization, that ligase IV also controls XRCC4 import, and that XLF is a new XRCC4-interacting NHEJ factor expanded the regulatory and compositional complexity of the NHEJ ligation complex.","evidence":"In vivo SUMOylation assay with K210R mutagenesis and subcellular fractionation; co-IP and siRNA of XLF; direct Ku70–XRCC4 interaction by live-cell imaging","pmids":["16478998","16439205","17124166"],"confidence":"High","gaps":["Whether SUMOylation is damage-regulated unknown","Structural basis of XLF–XRCC4 interaction not yet determined"]},{"year":2007,"claim":"Showing that XRCC4–ligase IV can ligate fully incompatible DNA ends and contributes to class switch recombination in B cells defined the remarkably flexible substrate scope and broader immune function of the complex.","evidence":"In vitro ligation with defined incompatible substrates; B-cell-specific conditional XRCC4 knockout mouse with CSR assay","pmids":["17290226","17606631"],"confidence":"High","gaps":["How the complex accommodates mismatched ends structurally unknown","Relative contribution of XRCC4/NHEJ vs. alternative end joining in CSR debated"]},{"year":2009,"claim":"A higher-resolution XRCC4–ligase IV BRCT structure revealed that BRCT2 makes essential contacts, refining the interface beyond the inter-BRCT linker model.","evidence":"X-ray crystallography with cellular complementation and dominant-negative overexpression","pmids":["19332554"],"confidence":"High","gaps":["Full-length ligase IV–XRCC4 structure lacking","How Ku docking alters the interface unknown"]},{"year":2011,"claim":"Crystal structures of XRCC4–XLF filaments revealed alternating head-to-head interactions forming a super-helical DNA-binding channel, establishing a structural paradigm for how NHEJ factors bridge and align broken ends.","evidence":"X-ray crystallography, SAXS, EM, site-directed mutagenesis, and isothermal titration calorimetry from two independent groups","pmids":["21775435","21768349"],"confidence":"High","gaps":["Whether filaments form in vivo at physiological concentrations unknown","How filament assembly is regulated by phosphorylation not determined"]},{"year":2015,"claim":"Identification of FBXW7-mediated K63-polyubiquitylation of XRCC4 at K296 (triggered by DNA-PKcs phosphorylation of S325/326 and ATM phosphorylation of FBXW7) enhancing Ku association, together with APLF FHA recognition of phospho-XRCC4, revealed a multi-layered PTM code on XRCC4 that fine-tunes NHEJ complex assembly.","evidence":"Mass spectrometry, ubiquitylation assays, mutagenesis, clonogenic survival; crystal structure of phospho-XRCC4–APLF FHA complex","pmids":["26774286","26519825"],"confidence":"High","gaps":["Whether K63-Ub serves as a platform for additional factor recruitment unknown","Interplay between SUMOylation, ubiquitylation, and phosphorylation not integrated"]},{"year":2016,"claim":"Single-molecule visualization of XRCC4–XLF complexes sliding along DNA and bridging two DNA molecules provided direct biophysical evidence for the mobile-sleeve model of end synapsis.","evidence":"Dual- and quadruple-trap optical tweezers with fluorescence microscopy","pmids":["27437582"],"confidence":"High","gaps":["Behavior in the context of chromatin and full NHEJ machinery not examined","How sliding converts to stable synapsis for ligation unknown"]},{"year":2017,"claim":"Phospho-mimicking mutations in XRCC4/XLF C-terminal tails selectively ablated DNA bridging without affecting ligase IV stimulation, demonstrating that DNA-PK/ATM phosphorylation separates the bridging and ligation-support functions; structural characterization of the PNKP–XRCC4–LigIV ternary complex by SAXS/HDX-MS defined multi-point contacts enabling coupled end-processing.","evidence":"Systematic mutagenesis of 14 phospho-sites with separation-of-function assays; SAXS, HDX-MS, and reconstitution of ternary complex","pmids":["28500754","28453785"],"confidence":"High","gaps":["Identity of the kinase(s) responsible for each site in vivo not fully resolved","Cryo-EM or crystal structure of full synaptic complex lacking"]},{"year":2021,"claim":"The finding that RIG-I competes with LIG4/XLF for XRCC4 binding, suppressing NHEJ while XRCC4 reciprocally enhances RIG-I innate immune signaling, revealed an unexpected crosstalk between DNA repair and antiviral immunity.","evidence":"Co-IP, DSB recruitment assay, in vitro ligation, RNA virus replication assay, mouse model","pmids":["33846346"],"confidence":"Medium","gaps":["Physiological contexts where this competition is dominant unknown","Whether RIG-I interaction is direct or mediated by RNA/DNA intermediates not fully resolved","Independent replication needed"]},{"year":null,"claim":"A high-resolution structure of the complete NHEJ synaptic complex — XRCC4–ligase IV–XLF filament assembled on DNA ends with Ku and DNA-PKcs — has not been determined, leaving the architecture of end synapsis and the mechanism by which phosphorylation-induced filament disassembly triggers ligation unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No cryo-EM or crystal structure of the full synaptic complex","Temporal sequence of PTM events during a single repair event not mapped in real time","Whether XRCC4–XLF filaments form on chromatin substrates in vivo remains undemonstrated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[1,16,37]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[8,30,38]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[9,13,30,31]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,18,29,32]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[17]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[0,1,10,11,16,35,38,39]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,23]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,23]}],"complexes":["XRCC4–DNA ligase IV","XRCC4–XLF filament","XRCC4–ligase IV–PNKP","Ku–XRCC4–ligase IV"],"partners":["LIG4","XLF","XRCC5","XRCC6","PNKP","APLF","FBXW7","PRKDC"],"other_free_text":[]},"mechanistic_narrative":"XRCC4 is a central scaffold protein of the non-homologous end joining (NHEJ) pathway that coordinates double-strand break repair and V(D)J recombination by nucleating the assembly of the core ligation machinery at DNA ends. XRCC4 forms a constitutive homodimer whose elongated coiled-coil binds asymmetrically to the inter-BRCT linker of DNA ligase IV in a 2:1 stoichiometry, stabilizing ligase IV protein levels and stimulating its adenylation and ligation activity, including ligation of incompatible DNA ends [PMID:9242410, PMID:11702069, PMID:14607114, PMID:17290226]. Ku70/80 recruits the XRCC4–ligase IV complex to DNA ends, while CK2 phosphorylation of XRCC4 creates docking sites recognized by the FHA domains of PNKP and APLF, coupling end-processing to ligation; XRCC4 also co-assembles with XLF into sliding filaments that bridge and align broken DNA molecules, an activity regulated by DNA-PK/ATM phosphorylation of the XRCC4 and XLF C-terminal tails [PMID:10757784, PMID:15385968, PMID:26519825, PMID:27437582, PMID:28500754]. Nuclear localization of XRCC4 depends on SUMOylation at K210 and on its interaction with ligase IV, and damage-induced K63-linked polyubiquitylation by FBXW7 enhances XRCC4–Ku association to promote NHEJ [PMID:16478998, PMID:26774286, PMID:24984242]."},"prefetch_data":{"uniprot":{"accession":"Q13426","full_name":"DNA repair protein XRCC4","aliases":["X-ray repair cross-complementing protein 4"],"length_aa":336,"mass_kda":38.3,"function":"DNA non-homologous end joining (NHEJ) core factor, required for double-strand break repair and V(D)J recombination (PubMed:10757784, PubMed:10854421, PubMed:12517771, PubMed:16412978, PubMed:17124166, PubMed:17290226, PubMed:22228831, PubMed:25597996, PubMed:25742519, PubMed:25934149, PubMed:26100018, PubMed:26774286, PubMed:8548796). Acts as a scaffold protein that regulates recruitment of other proteins to DNA double-strand breaks (DSBs) (PubMed:15385968, PubMed:20852255, PubMed:26774286, PubMed:27437582). Associates with NHEJ1/XLF to form alternating helical filaments that bridge DNA and act like a bandage, holding together the broken DNA until it is repaired (PubMed:21768349, PubMed:21775435, PubMed:22287571, PubMed:26100018, PubMed:27437582, PubMed:28500754). The XRCC4-NHEJ1/XLF subcomplex binds to the DNA fragments of a DSB in a highly diffusive manner and robustly bridges two independent DNA molecules, holding the broken DNA fragments in close proximity to one other (PubMed:27437582). The mobility of the bridges ensures that the ends remain accessible for further processing by other repair factors (PubMed:27437582). Plays a key role in the NHEJ ligation step of the broken DNA during DSB repair via direct interaction with DNA ligase IV (LIG4): the LIG4-XRCC4 subcomplex reseals the DNA breaks after the gap filling is completed (PubMed:10757784, PubMed:10854421, PubMed:12517771, PubMed:17290226, PubMed:19837014, PubMed:9242410). XRCC4 stabilizes LIG4, regulates its subcellular localization and enhances LIG4's joining activity (PubMed:10757784, PubMed:10854421, PubMed:12517771, PubMed:17290226, PubMed:21982441, PubMed:22228831, PubMed:9242410). Binding of the LIG4-XRCC4 subcomplex to DNA ends is dependent on the assembly of the DNA-dependent protein kinase complex DNA-PK to these DNA ends (PubMed:10757784, PubMed:10854421). Promotes displacement of PNKP from processed strand break termini (PubMed:20852255, PubMed:28453785) Acts as an activator of the phospholipid scramblase activity of XKR4 (PubMed:33725486). This form, which is generated upon caspase-3 (CASP3) cleavage, translocates into the cytoplasm and interacts with XKR4, thereby promoting phosphatidylserine scramblase activity of XKR4 and leading to phosphatidylserine exposure on apoptotic cell surface (PubMed:33725486)","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q13426/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/XRCC4","classification":"Not Classified","n_dependent_lines":151,"n_total_lines":1208,"dependency_fraction":0.125},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CSNK1A1","stoichiometry":4.0},{"gene":"DYNLL1","stoichiometry":0.2},{"gene":"DYNLL2","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/XRCC4","total_profiled":1310},"omim":[{"mim_id":"621368","title":"X KELL BLOOD GROUP PRECURSOR-RELATED FAMILY, MEMBER 4; XKR4","url":"https://www.omim.org/entry/621368"},{"mim_id":"620676","title":"COILED-COIL DOMAIN-CONTAINING PROTEIN 61; CCDC61","url":"https://www.omim.org/entry/620676"},{"mim_id":"618703","title":"ZINC FINGER PROTEIN 281; ZNF281","url":"https://www.omim.org/entry/618703"},{"mim_id":"616541","title":"SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED","url":"https://www.omim.org/entry/616541"},{"mim_id":"616315","title":"PAXX NONHOMOLOGOUS END JOINING FACTOR; PAXX","url":"https://www.omim.org/entry/616315"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/XRCC4"},"hgnc":{"alias_symbol":["hXRCC4"],"prev_symbol":[]},"alphafold":{"accession":"Q13426","domains":[{"cath_id":"2.170.210.10","chopping":"1-117","consensus_level":"high","plddt":93.7198,"start":1,"end":117},{"cath_id":"1.20.5","chopping":"119-186","consensus_level":"medium","plddt":97.9634,"start":119,"end":186}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13426","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q13426-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q13426-F1-predicted_aligned_error_v6.png","plddt_mean":74.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=XRCC4","jax_strain_url":"https://www.jax.org/strain/search?query=XRCC4"},"sequence":{"accession":"Q13426","fasta_url":"https://rest.uniprot.org/uniprotkb/Q13426.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q13426/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13426"}},"corpus_meta":[{"pmid":"16439205","id":"PMC_16439205","title":"XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16439205","citation_count":593,"is_preprint":false},{"pmid":"9242410","id":"PMC_9242410","title":"Activity of DNA ligase IV stimulated by complex formation with XRCC4 protein in mammalian cells.","date":"1997","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/9242410","citation_count":520,"is_preprint":false},{"pmid":"10786799","id":"PMC_10786799","title":"Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development.","date":"2000","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/10786799","citation_count":480,"is_preprint":false},{"pmid":"9259561","id":"PMC_9259561","title":"Mammalian DNA double-strand break repair protein XRCC4 interacts with DNA ligase IV.","date":"1997","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/9259561","citation_count":373,"is_preprint":false},{"pmid":"8548796","id":"PMC_8548796","title":"The XRCC4 gene encodes a novel protein involved in DNA double-strand break repair and V(D)J recombination.","date":"1995","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/8548796","citation_count":371,"is_preprint":false},{"pmid":"17124166","id":"PMC_17124166","title":"Dynamic assembly of end-joining complexes requires interaction between Ku70/80 and XRCC4.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17124166","citation_count":319,"is_preprint":false},{"pmid":"10757784","id":"PMC_10757784","title":"Ku recruits the XRCC4-ligase IV complex to DNA ends.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10757784","citation_count":297,"is_preprint":false},{"pmid":"25574025","id":"PMC_25574025","title":"DNA repair. PAXX, a paralog of XRCC4 and XLF, interacts with Ku to promote DNA double-strand break repair.","date":"2015","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/25574025","citation_count":244,"is_preprint":false},{"pmid":"11702069","id":"PMC_11702069","title":"Crystal structure of an Xrcc4-DNA ligase IV complex.","date":"2001","source":"Nature structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/11702069","citation_count":202,"is_preprint":false},{"pmid":"9826756","id":"PMC_9826756","title":"Double-strand break repair in Ku86- and XRCC4-deficient cells.","date":"1998","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/9826756","citation_count":194,"is_preprint":false},{"pmid":"15385968","id":"PMC_15385968","title":"Xrcc4 physically links DNA end processing by polynucleotide kinase to DNA ligation by DNA ligase IV.","date":"2004","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/15385968","citation_count":189,"is_preprint":false},{"pmid":"10854421","id":"PMC_10854421","title":"Interactions of the DNA ligase IV-XRCC4 complex with DNA ends and the DNA-dependent protein kinase.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10854421","citation_count":173,"is_preprint":false},{"pmid":"9430729","id":"PMC_9430729","title":"The XRCC4 gene product is a target for and interacts with the DNA-dependent protein kinase.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9430729","citation_count":153,"is_preprint":false},{"pmid":"10202163","id":"PMC_10202163","title":"DNA binding of Xrcc4 protein is associated with V(D)J recombination but not with stimulation of DNA ligase IV activity.","date":"1999","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10202163","citation_count":147,"is_preprint":false},{"pmid":"11080143","id":"PMC_11080143","title":"Crystal structure of the Xrcc4 DNA repair protein and implications for end joining.","date":"2000","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11080143","citation_count":146,"is_preprint":false},{"pmid":"10047779","id":"PMC_10047779","title":"Absence of DNA ligase IV protein in XR-1 cells: evidence for stabilization by XRCC4.","date":"1999","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/10047779","citation_count":144,"is_preprint":false},{"pmid":"25670504","id":"PMC_25670504","title":"Interactome analysis identifies a new paralogue of XRCC4 in non-homologous end joining DNA repair pathway.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25670504","citation_count":141,"is_preprint":false},{"pmid":"18093953","id":"PMC_18093953","title":"Defects in XRCC4 and KU80 differentially affect the joining of distal nonhomologous ends.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18093953","citation_count":139,"is_preprint":false},{"pmid":"21775435","id":"PMC_21775435","title":"XRCC4 protein interactions with XRCC4-like factor (XLF) create an extended grooved scaffold for DNA ligation and double strand break repair.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21775435","citation_count":137,"is_preprint":false},{"pmid":"9670033","id":"PMC_9670033","title":"Saccharomyces cerevisiae LIF1: a function involved in DNA double-strand break repair related to mammalian XRCC4.","date":"1998","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9670033","citation_count":136,"is_preprint":false},{"pmid":"17290226","id":"PMC_17290226","title":"XRCC4:DNA ligase IV can ligate incompatible DNA ends and can ligate across gaps.","date":"2007","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/17290226","citation_count":133,"is_preprint":false},{"pmid":"27437582","id":"PMC_27437582","title":"Sliding sleeves of XRCC4-XLF bridge DNA and connect fragments of broken DNA.","date":"2016","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/27437582","citation_count":127,"is_preprint":false},{"pmid":"22287571","id":"PMC_22287571","title":"A human XRCC4-XLF complex bridges DNA.","date":"2012","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/22287571","citation_count":121,"is_preprint":false},{"pmid":"15520013","id":"PMC_15520013","title":"DNA-dependent protein kinase and XRCC4-DNA ligase IV mobilization in the cell in response to DNA double strand breaks.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15520013","citation_count":119,"is_preprint":false},{"pmid":"17606631","id":"PMC_17606631","title":"Role for DNA repair factor XRCC4 in immunoglobulin class switch recombination.","date":"2007","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17606631","citation_count":118,"is_preprint":false},{"pmid":"9705934","id":"PMC_9705934","title":"DNA ligase IV binds to XRCC4 via a motif located between rather than within its BRCT domains.","date":"1998","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/9705934","citation_count":115,"is_preprint":false},{"pmid":"19332554","id":"PMC_19332554","title":"Structural and functional interaction between the human DNA repair proteins DNA ligase IV and XRCC4.","date":"2009","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19332554","citation_count":114,"is_preprint":false},{"pmid":"26774286","id":"PMC_26774286","title":"FBXW7 Facilitates Nonhomologous End-Joining via K63-Linked Polyubiquitylation of XRCC4.","date":"2016","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/26774286","citation_count":112,"is_preprint":false},{"pmid":"12140331","id":"PMC_12140331","title":"An xrcc4 defect or Wortmannin stimulates homologous recombination specifically induced by double-strand breaks in mammalian cells.","date":"2002","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/12140331","citation_count":110,"is_preprint":false},{"pmid":"21768349","id":"PMC_21768349","title":"Structural characterization of filaments formed by human Xrcc4-Cernunnos/XLF complex involved in nonhomologous DNA end-joining.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21768349","citation_count":107,"is_preprint":false},{"pmid":"14599745","id":"PMC_14599745","title":"DNA-PK phosphorylation sites in XRCC4 are not required for survival after radiation or for V(D)J recombination.","date":"2003","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/14599745","citation_count":104,"is_preprint":false},{"pmid":"17241822","id":"PMC_17241822","title":"Interaction of the Ku heterodimer with the DNA ligase IV/Xrcc4 complex and its regulation by DNA-PK.","date":"2007","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/17241822","citation_count":104,"is_preprint":false},{"pmid":"21070942","id":"PMC_21070942","title":"XLF regulates filament architecture of the XRCC4·ligase IV complex.","date":"2010","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/21070942","citation_count":98,"is_preprint":false},{"pmid":"16571728","id":"PMC_16571728","title":"Cernunnos interacts with the XRCC4 x DNA-ligase IV complex and is homologous to the yeast nonhomologous end-joining factor Nej1.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16571728","citation_count":97,"is_preprint":false},{"pmid":"18046455","id":"PMC_18046455","title":"Crystal structure of human XLF/Cernunnos reveals unexpected differences from XRCC4 with implications for NHEJ.","date":"2007","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/18046455","citation_count":94,"is_preprint":false},{"pmid":"19056826","id":"PMC_19056826","title":"XLF-Cernunnos promotes DNA ligase IV-XRCC4 re-adenylation following ligation.","date":"2008","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/19056826","citation_count":93,"is_preprint":false},{"pmid":"12509254","id":"PMC_12509254","title":"Defining interactions between DNA-PK and ligase IV/XRCC4.","date":"2002","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/12509254","citation_count":89,"is_preprint":false},{"pmid":"23442139","id":"PMC_23442139","title":"XRCC4 and XLF form long helical protein filaments suitable for DNA end protection and alignment to facilitate DNA double strand break repair.","date":"2013","source":"Biochemistry and cell biology = Biochimie et biologie cellulaire","url":"https://pubmed.ncbi.nlm.nih.gov/23442139","citation_count":89,"is_preprint":false},{"pmid":"18164646","id":"PMC_18164646","title":"A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients.","date":"2008","source":"Oral oncology","url":"https://pubmed.ncbi.nlm.nih.gov/18164646","citation_count":87,"is_preprint":false},{"pmid":"17317666","id":"PMC_17317666","title":"Length-dependent binding of human XLF to DNA and stimulation of XRCC4.DNA ligase IV activity.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17317666","citation_count":87,"is_preprint":false},{"pmid":"16478998","id":"PMC_16478998","title":"SUMO modification of human XRCC4 regulates its localization and function in DNA double-strand break repair.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16478998","citation_count":82,"is_preprint":false},{"pmid":"25166505","id":"PMC_25166505","title":"Canonical non-homologous end joining in mitosis induces genome instability and is suppressed by M-phase-specific phosphorylation of XRCC4.","date":"2014","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25166505","citation_count":77,"is_preprint":false},{"pmid":"27601299","id":"PMC_27601299","title":"Specific Roles of XRCC4 Paralogs PAXX and XLF during V(D)J Recombination.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27601299","citation_count":72,"is_preprint":false},{"pmid":"17987338","id":"PMC_17987338","title":"A novel single nucleotide polymorphism in XRCC4 gene is associated with gastric cancer susceptibility in Taiwan.","date":"2007","source":"Annals of surgical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/17987338","citation_count":68,"is_preprint":false},{"pmid":"25728776","id":"PMC_25728776","title":"Mutations in the NHEJ component XRCC4 cause primordial dwarfism.","date":"2015","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25728776","citation_count":66,"is_preprint":false},{"pmid":"27875301","id":"PMC_27875301","title":"An Intrinsically Disordered APLF Links Ku, DNA-PKcs, and XRCC4-DNA Ligase IV in an Extended Flexible Non-homologous End Joining Complex.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27875301","citation_count":60,"is_preprint":false},{"pmid":"19064702","id":"PMC_19064702","title":"Oncogenic transformation in the absence of Xrcc4 targets peripheral B cells that have undergone editing and switching.","date":"2008","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19064702","citation_count":58,"is_preprint":false},{"pmid":"21936820","id":"PMC_21936820","title":"Non-homologous end-joining partners in a helical dance: structural studies of XLF-XRCC4 interactions.","date":"2011","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/21936820","citation_count":57,"is_preprint":false},{"pmid":"14607114","id":"PMC_14607114","title":"Tetramerization and DNA ligase IV interaction of the DNA double-strand break repair protein XRCC4 are mutually exclusive.","date":"2003","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/14607114","citation_count":57,"is_preprint":false},{"pmid":"18558713","id":"PMC_18558713","title":"Werner protein cooperates with the XRCC4-DNA ligase IV complex in end-processing.","date":"2008","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18558713","citation_count":55,"is_preprint":false},{"pmid":"18165945","id":"PMC_18165945","title":"Polymorphisms of LIG4 and XRCC4 involved in the NHEJ pathway interact to modify risk of glioma.","date":"2008","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/18165945","citation_count":55,"is_preprint":false},{"pmid":"10922471","id":"PMC_10922471","title":"Cleavage and phosphorylation of XRCC4 protein induced by X-irradiation.","date":"2000","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/10922471","citation_count":53,"is_preprint":false},{"pmid":"16388993","id":"PMC_16388993","title":"Structure of an Xrcc4-DNA ligase IV yeast ortholog complex reveals a novel BRCT interaction mode.","date":"2006","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/16388993","citation_count":53,"is_preprint":false},{"pmid":"18383855","id":"PMC_18383855","title":"A new single nucleotide polymorphism in XRCC4 gene is associated with breast cancer susceptibility in Taiwanese patients.","date":"2008","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/18383855","citation_count":53,"is_preprint":false},{"pmid":"31067307","id":"PMC_31067307","title":"Amyotrophic lateral sclerosis-associated TDP-43 mutation Q331K prevents nuclear translocation of XRCC4-DNA ligase 4 complex and is linked to genome damage-mediated neuronal apoptosis.","date":"2019","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31067307","citation_count":53,"is_preprint":false},{"pmid":"20852255","id":"PMC_20852255","title":"Dual modes of interaction between XRCC4 and polynucleotide kinase/phosphatase: implications for nonhomologous end joining.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20852255","citation_count":52,"is_preprint":false},{"pmid":"17901044","id":"PMC_17901044","title":"Variation in DNA repair genes XRCC3, XRCC4, XRCC5 and susceptibility to myeloma.","date":"2007","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17901044","citation_count":52,"is_preprint":false},{"pmid":"23028374","id":"PMC_23028374","title":"De novo CNV formation in mouse embryonic stem cells occurs in the absence of Xrcc4-dependent nonhomologous end joining.","date":"2012","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23028374","citation_count":52,"is_preprint":false},{"pmid":"26100018","id":"PMC_26100018","title":"XRCC4/XLF Interaction Is Variably Required for DNA Repair and Is Not Required for Ligase IV Stimulation.","date":"2015","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/26100018","citation_count":50,"is_preprint":false},{"pmid":"25742519","id":"PMC_25742519","title":"An XRCC4 splice mutation associated with severe short stature, gonadal failure, and early-onset metabolic syndrome.","date":"2015","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/25742519","citation_count":50,"is_preprint":false},{"pmid":"17296606","id":"PMC_17296606","title":"Knockdown of DNA ligase IV/XRCC4 by RNA interference inhibits herpes simplex virus type I DNA replication.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17296606","citation_count":47,"is_preprint":false},{"pmid":"23788213","id":"PMC_23788213","title":"Genetic polymorphisms in DNA repair genes XRCC4 and XRCC5 and aflatoxin B1-related hepatocellular carcinoma.","date":"2013","source":"Epidemiology (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/23788213","citation_count":45,"is_preprint":false},{"pmid":"33846346","id":"PMC_33846346","title":"Reciprocal regulation of RIG-I and XRCC4 connects DNA repair with RIG-I immune signaling.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33846346","citation_count":44,"is_preprint":false},{"pmid":"19443403","id":"PMC_19443403","title":"Significant association of an XRCC4 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan.","date":"2009","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19443403","citation_count":44,"is_preprint":false},{"pmid":"28453785","id":"PMC_28453785","title":"Structural and functional characterization of the PNKP-XRCC4-LigIV DNA repair complex.","date":"2017","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/28453785","citation_count":43,"is_preprint":false},{"pmid":"20558749","id":"PMC_20558749","title":"Delineation of the Xrcc4-interacting region in the globular head domain of cernunnos/XLF.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20558749","citation_count":40,"is_preprint":false},{"pmid":"18630527","id":"PMC_18630527","title":"Association of XRCC4 codon 247 polymorphism with oral cancer susceptibility in Taiwan.","date":"2008","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/18630527","citation_count":40,"is_preprint":false},{"pmid":"17347130","id":"PMC_17347130","title":"The mutagenic potential of non-homologous end joining in the absence of the NHEJ core factors Ku70/80, DNA-PKcs and XRCC4-LigIV.","date":"2007","source":"Mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/17347130","citation_count":39,"is_preprint":false},{"pmid":"9352367","id":"PMC_9352367","title":"Molecular genetic characterization of XRCC4 function.","date":"1997","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9352367","citation_count":38,"is_preprint":false},{"pmid":"26300006","id":"PMC_26300006","title":"ZNF281 contributes to the DNA damage response by controlling the expression of XRCC2 and XRCC4.","date":"2015","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/26300006","citation_count":38,"is_preprint":false},{"pmid":"12218164","id":"PMC_12218164","title":"Identification of human autoantibodies to the DNA ligase IV/XRCC4 complex and mapping of an autoimmune epitope to a potential regulatory region.","date":"2002","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12218164","citation_count":37,"is_preprint":false},{"pmid":"12517771","id":"PMC_12517771","title":"Requirement for XRCC4 and DNA ligase IV in alignment-based gap filling for nonhomologous DNA end joining in vitro.","date":"2003","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/12517771","citation_count":37,"is_preprint":false},{"pmid":"17407264","id":"PMC_17407264","title":"Human DNA ligase IV and the ligase IV/XRCC4 complex: analysis of nick ligation fidelity.","date":"2007","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17407264","citation_count":36,"is_preprint":false},{"pmid":"20811692","id":"PMC_20811692","title":"The role of common variants of non-homologous end-joining repair genes XRCC4, LIG4 and Ku80 in thyroid cancer risk.","date":"2010","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/20811692","citation_count":36,"is_preprint":false},{"pmid":"20683005","id":"PMC_20683005","title":"Colorectal cancer and genetic polymorphism of DNA double-strand break repair gene XRCC4 in Taiwan.","date":"2010","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/20683005","citation_count":35,"is_preprint":false},{"pmid":"26026052","id":"PMC_26026052","title":"The TMPRSS2-ERG Gene Fusion Blocks XRCC4-Mediated Nonhomologous End-Joining Repair and Radiosensitizes Prostate Cancer Cells to PARP Inhibition.","date":"2015","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/26026052","citation_count":34,"is_preprint":false},{"pmid":"29747151","id":"PMC_29747151","title":"Role of PON1, SOD2, OGG1, XRCC1, and XRCC4 polymorphisms on modulation of DNA damage in workers occupationally exposed to pesticides.","date":"2018","source":"Ecotoxicology and environmental safety","url":"https://pubmed.ncbi.nlm.nih.gov/29747151","citation_count":34,"is_preprint":false},{"pmid":"21617942","id":"PMC_21617942","title":"Gene variants of XRCC4 and XRCC3 and their association with risk for urothelial bladder cancer.","date":"2011","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/21617942","citation_count":34,"is_preprint":false},{"pmid":"28500754","id":"PMC_28500754","title":"Mutational phospho-mimicry reveals a regulatory role for the XRCC4 and XLF C-terminal tails in modulating DNA bridging during classical non-homologous end joining.","date":"2017","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/28500754","citation_count":33,"is_preprint":false},{"pmid":"28696258","id":"PMC_28696258","title":"Effects of DNA end configuration on XRCC4-DNA ligase IV and its stimulation of Artemis activity.","date":"2017","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28696258","citation_count":30,"is_preprint":false},{"pmid":"29415984","id":"PMC_29415984","title":"UHRF1 depletion sensitizes retinoblastoma cells to chemotherapeutic drugs via downregulation of XRCC4.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/29415984","citation_count":29,"is_preprint":false},{"pmid":"25839420","id":"PMC_25839420","title":"Mutations in XRCC4 cause primary microcephaly, short stature and increased genomic instability.","date":"2015","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25839420","citation_count":29,"is_preprint":false},{"pmid":"31141305","id":"PMC_31141305","title":"Genetic interaction between DNA repair factors PAXX, XLF, XRCC4 and DNA-PKcs in human cells.","date":"2019","source":"FEBS open bio","url":"https://pubmed.ncbi.nlm.nih.gov/31141305","citation_count":24,"is_preprint":false},{"pmid":"24984242","id":"PMC_24984242","title":"DNA Ligase IV regulates XRCC4 nuclear localization.","date":"2014","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/24984242","citation_count":23,"is_preprint":false},{"pmid":"26519825","id":"PMC_26519825","title":"Versatility in phospho-dependent molecular recognition of the XRCC1 and XRCC4 DNA-damage scaffolds by aprataxin-family FHA domains.","date":"2015","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/26519825","citation_count":23,"is_preprint":false},{"pmid":"21296624","id":"PMC_21296624","title":"An analysis of single nucleotide polymorphisms of 125 DNA repair genes in the Texas genome-wide association study of lung cancer with a replication for the XRCC4 SNPs.","date":"2011","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/21296624","citation_count":23,"is_preprint":false},{"pmid":"19837014","id":"PMC_19837014","title":"Electron microscopy of Xrcc4 and the DNA ligase IV-Xrcc4 DNA repair complex.","date":"2009","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/19837014","citation_count":23,"is_preprint":false},{"pmid":"16227403","id":"PMC_16227403","title":"Radiosensitization of MDA-MB-231 breast tumor cells by adenovirus-mediated overexpression of a fragment of the XRCC4 protein.","date":"2005","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/16227403","citation_count":23,"is_preprint":false},{"pmid":"20332465","id":"PMC_20332465","title":"Significant association of XRCC4 single nucleotide polymorphisms with childhood leukemia in Taiwan.","date":"2010","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/20332465","citation_count":23,"is_preprint":false},{"pmid":"19729825","id":"PMC_19729825","title":"Lung cancer susceptibility and genetic polymorphism of DNA repair gene XRCC4 in Taiwan.","date":"2009","source":"Cancer biomarkers : section A of Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/19729825","citation_count":23,"is_preprint":false},{"pmid":"21982441","id":"PMC_21982441","title":"XRCC4 controls nuclear import and distribution of Ligase IV and exchanges faster at damaged DNA in complex with Ligase IV.","date":"2011","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/21982441","citation_count":23,"is_preprint":false},{"pmid":"20448413","id":"PMC_20448413","title":"Radiation-induced XRCC4 association with chromatin DNA analyzed by biochemical fractionation.","date":"2010","source":"Journal of radiation research","url":"https://pubmed.ncbi.nlm.nih.gov/20448413","citation_count":22,"is_preprint":false},{"pmid":"29511619","id":"PMC_29511619","title":"Normal development of mice lacking PAXX, the paralogue of XRCC4 and XLF.","date":"2018","source":"FEBS open bio","url":"https://pubmed.ncbi.nlm.nih.gov/29511619","citation_count":22,"is_preprint":false},{"pmid":"23064322","id":"PMC_23064322","title":"Agrobacterium may delay plant nonhomologous end-joining DNA repair via XRCC4 to favor T-DNA integration.","date":"2012","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/23064322","citation_count":22,"is_preprint":false},{"pmid":"16835328","id":"PMC_16835328","title":"A role for XRCC4 in age at diagnosis and breast cancer risk.","date":"2006","source":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/16835328","citation_count":22,"is_preprint":false},{"pmid":"21479444","id":"PMC_21479444","title":"Significant association of XRCC4 single nucleotide polymorphisms with prostate cancer susceptibility in Taiwanese males.","date":"2008","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/21479444","citation_count":22,"is_preprint":false},{"pmid":"30842344","id":"PMC_30842344","title":"Silencing of XRCC4 increases radiosensitivity of triple-negative breast cancer cells.","date":"2019","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/30842344","citation_count":21,"is_preprint":false},{"pmid":"18759011","id":"PMC_18759011","title":"Increased gene targeting in Ku70 and Xrcc4 transiently deficient human somatic cells.","date":"2008","source":"Molecular biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/18759011","citation_count":21,"is_preprint":false},{"pmid":"22740656","id":"PMC_22740656","title":"Terminal deoxynucleotidyl transferase requires KU80 and XRCC4 to promote N-addition at non-V(D)J chromosomal breaks in non-lymphoid cells.","date":"2012","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/22740656","citation_count":20,"is_preprint":false},{"pmid":"21785230","id":"PMC_21785230","title":"Differences in sensitivity to DNA-damaging Agents between XRCC4- and Artemis-deficient human cells.","date":"2011","source":"Journal of radiation research","url":"https://pubmed.ncbi.nlm.nih.gov/21785230","citation_count":19,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47978,"output_tokens":8578,"usd":0.136302},"stage2":{"model":"claude-opus-4-6","input_tokens":12521,"output_tokens":4145,"usd":0.249345},"total_usd":0.385647,"stage1_batch_id":"msgbatch_01BparvgRZ9S2LMidvaoo86K","stage2_batch_id":"msgbatch_01NkBfv9SVZWthhS7j6mU6G3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"XRCC4 encodes a novel nuclear protein required for completion of V(D)J recombination (both coding and signal joints) and DNA double-strand break repair, as demonstrated by functional complementation of XRCC4-deleted XR-1 CHO cells.\",\n      \"method\": \"cDNA cloning, functional complementation of mutant cell line, V(D)J recombination assay\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO complementation with defined cellular phenotype, foundational paper\",\n      \"pmids\": [\"8548796\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"XRCC4 directly interacts with DNA ligase IV and stimulates its ligation activity 5–8 fold, establishing that XRCC4's biological function is primarily to potentiate DNA ligase IV for double-strand break ligation and V(D)J recombination.\",\n      \"method\": \"Co-immunoprecipitation, yeast two-hybrid, in vitro ligation assay with purified recombinant proteins\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with purified proteins plus co-IP, replicated by multiple labs\",\n      \"pmids\": [\"9242410\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"XRCC4 interacts with DNA ligase IV via the ligase IV carboxy-terminal extension containing tandem BRCT motifs, and XRCC4 is a nuclear phosphoprotein that serves as an efficient substrate for DNA-PK in vitro.\",\n      \"method\": \"Co-immunoprecipitation, co-purification over multiple chromatographic steps, adenylylation assay, in vitro kinase assay\",\n      \"journal\": \"Current Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reciprocal co-IP plus biochemical co-purification and functional assay\",\n      \"pmids\": [\"9259561\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"XRCC4 forms a homodimer in vivo with the dimerization domain mapping to amino acids 115–204, and the core domain required for V(D)J recombination comprises amino acids 18–204.\",\n      \"method\": \"Yeast two-hybrid, deletion mutagenesis, transient V(D)J recombination assay\",\n      \"journal\": \"International Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — deletion mapping combined with functional assay, single lab\",\n      \"pmids\": [\"9352367\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"DNA ligase IV binds XRCC4 via a region located between (not within) its two BRCT domains; this inter-BRCT linker region is necessary and sufficient for XRCC4 binding.\",\n      \"method\": \"Deletion analysis of ligase IV, co-immunoprecipitation\",\n      \"journal\": \"Current Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic deletion mapping with co-IP, mechanistically precise\",\n      \"pmids\": [\"9705934\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"XRCC4 is phosphorylated in vitro by DNA-PK (and an unidentified kinase) on serine/threonine residues within its C-terminal 130 amino acids, and XRCC4 facilitates Ku binding to DNA, promoting DNA-PK complex assembly.\",\n      \"method\": \"In vitro kinase assay with recombinant proteins, Sf9 insect-cell expression, DNA-binding assay\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro assay with purified proteins, single lab\",\n      \"pmids\": [\"9430729\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The yeast XRCC4 ortholog LIF1 interacts with the C-terminal BRCT domain of yeast Lig4, occurs as a Lig4-LIF1 heterodimer in vivo, stabilizes Lig4, and is required for non-homologous end joining; LIF1 disruption phenocopies lig4 mutants.\",\n      \"method\": \"Yeast two-hybrid, gene disruption, plasmid end-joining assay, Western blot for protein stability\",\n      \"journal\": \"EMBO Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in yeast ortholog, replicated concept\",\n      \"pmids\": [\"9670033\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"XRCC4 is required to stabilize DNA ligase IV protein (not mRNA) in cells; in XRCC4-deficient XR-1 cells, ligase IV protein is nearly undetectable, and reintroduction of XRCC4 restores ligase IV to wild-type levels.\",\n      \"method\": \"Western blot for protein levels, Northern blot for mRNA, complementation of XR-1 cells\",\n      \"journal\": \"Mutation Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — complementation experiment with protein and mRNA analysis, replicated concept\",\n      \"pmids\": [\"10047779\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"XRCC4 binds DNA with preference for nicked or broken ends; the DNA-binding activity correlates with complementation of V(D)J recombination defects but is not required for stimulation of DNA ligase IV adenylation.\",\n      \"method\": \"DNA-binding assay, in vitro ligation assay, complementation of XRCC4-deficient cells\",\n      \"journal\": \"EMBO Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro biochemical assays plus cellular complementation, separation of function\",\n      \"pmids\": [\"10202163\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"XRCC4 crystal structure reveals an elongated dumbbell-shaped tetramer with an N-terminal globular head containing a putative DNA-binding HTH motif and a long C-terminal coiled-coil stalk that mediates ligase IV interaction and tetramerization.\",\n      \"method\": \"X-ray crystallography at 2.7 Å resolution\",\n      \"journal\": \"EMBO Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with functional domain interpretation\",\n      \"pmids\": [\"11080143\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The XRCC4-ligase IV complex directly binds Ku at DNA ends; Ku is required to recruit XRCC4-ligase IV to DNA ends, and this recruitment stimulates the initial ligation rate 20-fold in vitro.\",\n      \"method\": \"Direct protein-protein interaction assay, in vitro ligation assay, DNA-binding assay\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro reconstitution with purified proteins, quantitative kinetics\",\n      \"pmids\": [\"10757784\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"DNA ligase IV-XRCC4 complex binds specifically to DNA ends and can act as a bridging factor linking DNA molecules; DNA-PKcs (but not Ku alone) stimulates intermolecular ligation by the complex.\",\n      \"method\": \"In vitro ligation assay, DNA end-binding assay, protein-protein interaction at DNA ends\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with multiple purified components\",\n      \"pmids\": [\"10854421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"p53 deficiency rescues embryonic lethality and neuronal apoptosis caused by XRCC4 deficiency in mice, placing XRCC4 upstream of p53-dependent apoptosis; XRCC4-null/p53-null mice develop pro-B-cell lymphomas with IgH-c-myc translocations.\",\n      \"method\": \"Genetic epistasis in double-knockout mice, tumor analysis, cytogenetics\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in mouse model with defined phenotypic readout\",\n      \"pmids\": [\"10786799\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Crystal structure of XRCC4 bound to the inter-BRCT linker peptide of DNA ligase IV reveals that one ligase chain binds asymmetrically to an XRCC4 dimer; XRCC4 helical tails form a coiled-coil that unwinds upon ligase binding, creating a flat interaction surface stabilized by charged hydrogen bonds and hydrophobic contacts.\",\n      \"method\": \"X-ray crystallography\",\n      \"journal\": \"Nature Structural Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure of the complex\",\n      \"pmids\": [\"11702069\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"DNA-PK phosphorylates XRCC4 at serines 260 and 318 in the C-terminal region in vitro, but substitution of all phosphorylation sites to alanine does not impair cell survival after ionizing radiation or V(D)J recombination.\",\n      \"method\": \"Mass spectrometry mapping, site-directed mutagenesis, clonogenic survival assay, V(D)J recombination assay\",\n      \"journal\": \"DNA Repair\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — MS-based site mapping combined with mutagenesis and functional cellular assays\",\n      \"pmids\": [\"14599745\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"XRCC4 dimer binds DNA ligase IV in a 2:1 stoichiometry in solution; tetramerization of XRCC4 and DNA ligase IV binding are mutually exclusive because they share overlapping interfaces.\",\n      \"method\": \"Equilibrium sedimentation, mutational analysis, size-exclusion chromatography\",\n      \"journal\": \"Journal of Molecular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — biophysical analysis with mutagenesis defining stoichiometry and mutual exclusivity\",\n      \"pmids\": [\"14607114\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"XRCC4 physically links polynucleotide kinase (PNK) to DNA ligase IV: CK2-phosphorylated XRCC4 is recognized by the FHA domain of PNK, and disruption of this interaction in vivo increases radiosensitivity and slows DSB repair kinetics.\",\n      \"method\": \"Co-immunoprecipitation, phosphopeptide binding, in vitro end-joining assay, cellular repair kinetics\",\n      \"journal\": \"EMBO Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including in vitro and cellular assays\",\n      \"pmids\": [\"15385968\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"DSB induction causes DNA-PK-dependent phosphorylation and mobilization of XRCC4-ligase IV from the soluble nucleoplasm to a less-extractable nuclear fraction; DNA-PKcs is required for XRCC4-ligase IV complex recruitment, and ligase IV is needed for stable XRCC4 recruitment.\",\n      \"method\": \"Biochemical fractionation, co-immunoprecipitation, siRNA knockdown in human cells, laser-induced DSBs\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — fractionation with functional requirements established by dependency experiments\",\n      \"pmids\": [\"15520013\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"XRCC4 is SUMOylated at lysine 210; this modification is required for nuclear localization of XRCC4, and a SUMOylation-deficient mutant remains cytoplasmic, causes radiation sensitivity, and fails to support V(D)J recombination.\",\n      \"method\": \"In vitro and in vivo SUMOylation assay, site-directed mutagenesis, subcellular fractionation, clonogenic survival, V(D)J assay\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — PTM mapping with mutagenesis and functional cellular readouts\",\n      \"pmids\": [\"16478998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"XLF (XRCC4-like factor/Cernunnos) directly interacts with the XRCC4-ligase IV complex in vitro and in vivo; siRNA depletion of XLF causes radiosensitivity and impaired NHEJ, identifying XLF as a core NHEJ component.\",\n      \"method\": \"Co-immunoprecipitation, in vitro pulldown, siRNA knockdown, clonogenic survival, NHEJ assay\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP plus in vitro interaction plus functional cellular assays, replicated\",\n      \"pmids\": [\"16439205\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Cernunnos/XLF physically interacts with the XRCC4-ligase IV complex and is the human homolog of yeast Nej1, connecting the NHEJ ligation complex across eukaryotes.\",\n      \"method\": \"Co-immunoprecipitation, sequence analysis, structural prediction\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single co-IP plus computational analysis\",\n      \"pmids\": [\"16571728\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"XRCC4 directly interacts with Ku70, and XRCC4-ligase IV accumulation at DSBs depends on Ku70/80 but not DNA-PKcs, suggesting Ku serves as a flexible tether between Ku70/80 and ligase IV via XRCC4.\",\n      \"method\": \"Pulsed near-IR laser DSB induction, live-cell imaging (FRAP), direct protein-protein interaction assay\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct interaction assay combined with live-cell imaging and kinetic analysis\",\n      \"pmids\": [\"17124166\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"XRCC4:DNA ligase IV can ligate two DNA ends with fully incompatible 3' overhangs (no base pairing) and can ligate across 1 nt gaps; this intrinsic flexibility of the complex explains in vivo end-joining at mismatched ends.\",\n      \"method\": \"In vitro ligation assay with defined incompatible DNA substrates, purified human XRCC4:Lig4\",\n      \"journal\": \"EMBO Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with defined substrates and purified proteins\",\n      \"pmids\": [\"17290226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"XRCC4 plays a role in immunoglobulin class switch recombination (CSR); B-lymphocyte-specific conditional XRCC4 knockout reduces CSR approximately 2-fold in vivo and in vitro.\",\n      \"method\": \"Conditional knockout mouse (loxP/Cre), in vivo and in vitro CSR assay\",\n      \"journal\": \"Journal of Experimental Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with defined cellular phenotype\",\n      \"pmids\": [\"17606631\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Ku interacts with DNA ligase IV via the first BRCT motif of ligase IV; this interaction is enhanced by XRCC4 and dsDNA; DNA-PK kinase activity causes disassembly of the Ku/DNA ligase IV/XRCC4 complex.\",\n      \"method\": \"Pulldown assay, deletion mapping, in vitro kinase assay\",\n      \"journal\": \"DNA Repair\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — pulldown with deletion mapping, single lab\",\n      \"pmids\": [\"17241822\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"XLF promotes re-adenylation of the ligase IV-XRCC4 complex after ligation, allowing in situ recharging of ligase IV to facilitate double-strand ligation by a single complex; XLF is a weakly bound partner of the tight LX complex.\",\n      \"method\": \"Biochemical adenylation assay, in vitro ligation assay, cellular DSB repair kinetics\",\n      \"journal\": \"Nucleic Acids Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro biochemical dissection of mechanism combined with cellular assays\",\n      \"pmids\": [\"19056826\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Werner protein (WRN) physically interacts with the XRCC4-DNA ligase IV complex; this interaction stimulates WRN exonuclease (but not helicase) activity, and WRN-processed substrates are subsequently ligated by XRCC4-ligase IV, coordinating end processing with ligation.\",\n      \"method\": \"Co-immunoprecipitation, in vitro exonuclease assay, in vitro ligation assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP plus in vitro functional assay, single lab\",\n      \"pmids\": [\"18558713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"High-resolution crystal structure of human XRCC4 bound to the tandem BRCT repeat of DNA ligase IV reveals an extensive binding interface formed by a helix-loop-helix in the inter-BRCT linker plus significant contacts from the second BRCT domain, inducing a kink in the XRCC4 tail; interaction with the second BRCT domain is necessary for stable binding in cells.\",\n      \"method\": \"X-ray crystallography, cellular complementation, dominant-negative overexpression\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure plus cellular functional validation\",\n      \"pmids\": [\"19332554\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Unphosphorylated XRCC4 interacts with the catalytic domain of PNKP (stimulating PNKP turnover), while CK2-phosphorylated XRCC4 binds the PNKP FHA domain with high affinity but inhibits PNKP activity; the XRCC4-ligase IV complex also stimulates PNKP turnover independently of XRCC4 phosphorylation.\",\n      \"method\": \"In vitro kinase assay, pulldown/co-IP, in vitro PNKP activity assay\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple in vitro assays, single lab\",\n      \"pmids\": [\"20852255\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"DNA ligase IV controls nuclear localization and stability of XRCC4: in ligase IV-deficient cells, XRCC4 remains cytoplasmic even after DSB induction; ligase IV also regulates nuclear import of XLF.\",\n      \"method\": \"Subcellular fractionation, immunofluorescence, Western blot in ligase IV-deficient cells\",\n      \"journal\": \"DNA Repair\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiment with functional consequence, single lab\",\n      \"pmids\": [\"24984242\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"XRCC4 and XLF form alternating parallel super-helical filaments via head-domain interactions (XLF Leu-115 'Leu-lock' inserts into a hydrophobic XRCC4 pocket); these filaments form a positively charged DNA-binding channel that aligns ends for ligation.\",\n      \"method\": \"X-ray crystallography, SAXS, site-directed mutagenesis, biophysical analysis\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure combined with mutagenesis and SAXS, multiple orthogonal methods\",\n      \"pmids\": [\"21775435\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Crystal structure of XLF-XRCC4 complex at 3.94 Å confirms filament arrangement; four XRCC4 residues (Glu55, Asp58, Met61, Phe106) are essential for XLF interaction as determined by mutagenesis and calorimetry.\",\n      \"method\": \"X-ray crystallography, electron microscopy, site-directed mutagenesis, isothermal titration calorimetry\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure combined with mutagenesis and calorimetric validation\",\n      \"pmids\": [\"21768349\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"XRCC4 controls nuclear import and sub-nuclear distribution of DNA ligase IV; when co-expressed with XRCC4, ligase IV is efficiently imported and distributes like XRCC4; the XRCC4-ligase IV complex exchanges faster at DNA damage sites than XRCC4 alone.\",\n      \"method\": \"Fluorescent fusion protein expression, live-cell imaging, FRAP, nuclear fractionation\",\n      \"journal\": \"DNA Repair\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct live-cell imaging with functional consequence, single lab\",\n      \"pmids\": [\"21982441\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"XRCC4-XLF complexes robustly bridge two independent DNA molecules; this bridging activity is DNA ligase IV-independent and suggests an early role for the complex in holding broken DNA ends together prior to ligation.\",\n      \"method\": \"DNA bridging assay, direct visualization, crystal structure at 3.94 Å, mutational analysis\",\n      \"journal\": \"Nucleic Acids Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — biochemical bridging assays combined with crystal structure and mutagenesis\",\n      \"pmids\": [\"22287571\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"XRCC4 undergoes M-phase-specific phosphorylation requiring CDK activity and Plk1; a phosphorylation-defective XRCC4 mutant shows more efficient M-phase DSB repair but increased anaphase bridge formation, indicating this phosphorylation suppresses NHEJ during mitosis to prevent genomic instability.\",\n      \"method\": \"Site-directed mutagenesis, kinase inhibition, live-cell imaging, chromosome analysis\",\n      \"journal\": \"PLOS Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis with cellular phenotype, single lab\",\n      \"pmids\": [\"25166505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"FBXW7-mediated K63-linked polyubiquitylation of XRCC4 at lysine 296 (triggered by DNA-PKcs phosphorylation of XRCC4 at Ser325/326 after IR and ATM phosphorylation of FBXW7 at Ser26) enhances XRCC4 association with Ku70/80 to facilitate NHEJ.\",\n      \"method\": \"Co-immunoprecipitation, mass spectrometry, site-directed mutagenesis, in vivo ubiquitylation assay, clonogenic survival\",\n      \"journal\": \"Molecular Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods identifying PTM writer (SCF-FBXW7), modification site, and functional consequence\",\n      \"pmids\": [\"26774286\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"PAXX (paralog of XRCC4 and XLF) has a crystal structure resembling XRCC4, directly interacts with Ku (not XRCC4 directly), and is recruited to DSB sites; PAXX promotes Ku-dependent DNA ligation in vitro and functions together with XRCC4 and XLF in NHEJ.\",\n      \"method\": \"X-ray crystallography, co-immunoprecipitation, CRISPR-Cas9 knockout, in vitro ligation assay, chromatin fractionation\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — crystal structure combined with genetic KO and in vitro reconstitution\",\n      \"pmids\": [\"25574025\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CK2-phosphorylated XRCC4 is recognized by the FHA domain of APLF; crystal structure of the phospho-XRCC4-APLF complex reveals the binding mode and shows distinct but overlapping specificities among FHA domain family members for XRCC4 vs. XRCC1 scaffolds.\",\n      \"method\": \"X-ray crystallography, NMR, biochemical binding assays\",\n      \"journal\": \"DNA Repair\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with NMR and biochemical validation\",\n      \"pmids\": [\"26519825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"XRCC4-XLF complexes form mobile sleeve-like structures that can slide along DNA and bridge two independent DNA molecules; XLF stimulates XRCC4 binding to DNA, and the resulting heteromeric complexes diffuse swiftly along DNA, enabling rapid reconnection of broken ends.\",\n      \"method\": \"Dual- and quadruple-trap optical tweezers with fluorescence microscopy (single-molecule)\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — single-molecule biophysical reconstitution with direct real-time observation\",\n      \"pmids\": [\"27437582\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Phospho-mimicking mutations in the C-terminal tails of both XRCC4 and XLF reduce stability and DNA-bridging capacity of XRCC4/XLF filaments without affecting their ability to stimulate ligase IV activity, indicating that DNA-PK/ATM phosphorylation of these tails specifically regulates DNA bridging.\",\n      \"method\": \"Site-directed mutagenesis (14 phosphorylation sites), in vitro DNA bridging assay, ligation stimulation assay\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — systematic mutagenesis with separation-of-function between bridging and ligation stimulation\",\n      \"pmids\": [\"28500754\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"XRCC4-ligase IV complex stimulates Artemis endonuclease activity on 3' overhangs in a DNA-PKcs-independent manner; X4-LIV and DNA-PKcs interfere with each other in stimulating Artemis, supporting sequential rather than concurrent recruitment.\",\n      \"method\": \"In vitro nuclease assay, in vitro ligation assay with defined DNA substrates\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution, single lab\",\n      \"pmids\": [\"28696258\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The PNKP-XRCC4-LigIV complex requires XRCC4 phosphorylation for stable PNKP binding (one PNKP per XRCC4 dimer); SAXS and hydrogen-deuterium exchange reveal that PNKP makes multipoint contacts with XRCC4 coiled-coil and LigIV BRCT repeats; a disease mutation E326K on the PNKP phosphatase domain surface impairs PNKP recruitment to DSBs.\",\n      \"method\": \"SAXS, HDX-MS, in vitro complex reconstitution, site-directed mutagenesis, cellular recruitment assay\",\n      \"journal\": \"Nucleic Acids Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted complex characterized by multiple structural and biochemical methods\",\n      \"pmids\": [\"28453785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"RIG-I interacts with XRCC4 and the RIG-I/XRCC4 interaction impedes formation of the XRCC4/LIG4/XLF complex at DSBs, suppressing NHEJ; reciprocally, XRCC4 promotes RIG-I immune signaling by enhancing RIG-I oligomerization and ubiquitination.\",\n      \"method\": \"Co-immunoprecipitation, DSB recruitment assay, in vitro ligation assay, RNA virus replication assay, mouse model\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP plus functional in vitro and in vivo assays, single lab\",\n      \"pmids\": [\"33846346\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"XRCC4 is a dimeric scaffold protein that forms a tight constitutive complex with DNA ligase IV (via the inter-BRCT linker of ligase IV binding to the XRCC4 coiled-coil), stabilizing ligase IV and stimulating its adenylation and ligation activity; after DSB induction, Ku70/80 (which directly contacts XRCC4) recruits the XRCC4-ligase IV complex to DNA ends where XRCC4 also scaffolds PNK/PNKP (via CK2-phosphorylated XRCC4 recognized by the PNKP FHA domain) to coordinate end processing with ligation; XRCC4 additionally co-assembles with XLF into dynamic, sliding filaments that bridge and align broken DNA ends, an activity regulated by DNA-PK/ATM phosphorylation of their C-terminal tails, while nuclear localization of XRCC4 itself depends on SUMOylation at K210 and on its interaction with ligase IV.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"XRCC4 is a central scaffold protein of the non-homologous end joining (NHEJ) pathway that coordinates double-strand break repair and V(D)J recombination by nucleating the assembly of the core ligation machinery at DNA ends. XRCC4 forms a constitutive homodimer whose elongated coiled-coil binds asymmetrically to the inter-BRCT linker of DNA ligase IV in a 2:1 stoichiometry, stabilizing ligase IV protein levels and stimulating its adenylation and ligation activity, including ligation of incompatible DNA ends [PMID:9242410, PMID:11702069, PMID:14607114, PMID:17290226]. Ku70/80 recruits the XRCC4–ligase IV complex to DNA ends, while CK2 phosphorylation of XRCC4 creates docking sites recognized by the FHA domains of PNKP and APLF, coupling end-processing to ligation; XRCC4 also co-assembles with XLF into sliding filaments that bridge and align broken DNA molecules, an activity regulated by DNA-PK/ATM phosphorylation of the XRCC4 and XLF C-terminal tails [PMID:10757784, PMID:15385968, PMID:26519825, PMID:27437582, PMID:28500754]. Nuclear localization of XRCC4 depends on SUMOylation at K210 and on its interaction with ligase IV, and damage-induced K63-linked polyubiquitylation by FBXW7 enhances XRCC4–Ku association to promote NHEJ [PMID:16478998, PMID:26774286, PMID:24984242].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Identifying XRCC4 as a gene required for both V(D)J recombination and DSB repair established that a previously unknown nuclear factor was essential for the final joining step of NHEJ.\",\n      \"evidence\": \"cDNA cloning and functional complementation of the XRCC4-deficient XR-1 CHO cell line\",\n      \"pmids\": [\"8548796\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No binding partners or biochemical activity identified\", \"Mechanism of action unknown\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Discovery that XRCC4 directly binds and stimulates DNA ligase IV, and that their interaction maps to the ligase IV C-terminal BRCT region, defined XRCC4's primary molecular role as a ligase IV cofactor.\",\n      \"evidence\": \"Co-IP, yeast two-hybrid, and in vitro ligation assays with purified recombinant proteins; co-purification and adenylation assays\",\n      \"pmids\": [\"9242410\", \"9259561\", \"9352367\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise binding interface not resolved\", \"Stoichiometry uncertain\", \"How the complex is recruited to DSBs unknown\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Mapping the ligase IV binding site to the inter-BRCT linker (not the BRCT domains themselves) and showing XRCC4 is a DNA-PK substrate placed XRCC4 in a regulated signaling context at DSBs.\",\n      \"evidence\": \"Systematic deletion analysis with co-IP; in vitro kinase assay with purified DNA-PK; yeast ortholog LIF1 disruption phenocopying lig4 mutants\",\n      \"pmids\": [\"9705934\", \"9430729\", \"9670033\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of DNA-PK phosphorylation unknown\", \"In vivo recruitment mechanism unresolved\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstrating that XRCC4 stabilizes ligase IV at the protein level and that XRCC4 binds DNA with preference for nicked/broken ends separated its stabilization function from its DNA-end recognition activity.\",\n      \"evidence\": \"Western/Northern blot in XR-1 cells with XRCC4 complementation; DNA-binding assays and in vitro ligation with separation-of-function mutants\",\n      \"pmids\": [\"10047779\", \"10202163\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"DNA-binding surface not structurally defined\", \"How DNA binding contributes to in vivo repair unclear\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Crystal structure of XRCC4, combined with reconstitution of Ku-dependent end recruitment and DNA bridging by XRCC4–ligase IV, established the architectural framework of the NHEJ ligation complex and showed that Ku is the DNA-end recruiter.\",\n      \"evidence\": \"X-ray crystallography at 2.7 Å; in vitro reconstitution with Ku and DNA-PKcs showing 20-fold ligation stimulation; genetic epistasis in XRCC4/p53 double-KO mice\",\n      \"pmids\": [\"11080143\", \"10757784\", \"10854421\", \"10786799\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of the XRCC4–ligase IV complex not yet solved\", \"Stoichiometry in vivo debated (tetramer vs. dimer)\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"The crystal structure of the XRCC4–ligase IV inter-BRCT linker complex revealed how one ligase IV chain binds asymmetrically to the XRCC4 dimer, unwinding the coiled-coil to create a flat interface — resolving the binding mode.\",\n      \"evidence\": \"X-ray crystallography of the binary complex\",\n      \"pmids\": [\"11702069\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Role of BRCT2 contacts not captured at this resolution\", \"How tetramerization and ligase IV binding are regulated not clear\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Establishing 2:1 XRCC4 dimer:ligase IV stoichiometry and mutual exclusivity with tetramerization resolved a structural ambiguity, while showing that DNA-PK phosphorylation sites on XRCC4 are dispensable for survival and V(D)J recombination raised the question of what these modifications do.\",\n      \"evidence\": \"Equilibrium sedimentation and size-exclusion chromatography; mass spectrometry phosphosite mapping with alanine mutagenesis and functional assays\",\n      \"pmids\": [\"14607114\", \"14599745\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional role of DNA-PK phosphorylation on XRCC4 unresolved\", \"Whether tetramer has any physiological role unclear\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identification of CK2-phosphorylated XRCC4 as the bridge linking PNKP to the ligation complex, and demonstration that DNA-PKcs drives XRCC4–ligase IV mobilization to DSBs, established XRCC4 as an actively regulated scaffold coupling end-processing with ligation.\",\n      \"evidence\": \"Co-IP, phosphopeptide binding with FHA domain, cellular repair kinetics; biochemical fractionation with siRNA knockdown\",\n      \"pmids\": [\"15385968\", \"15520013\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of CK2-phospho-XRCC4/PNKP FHA interaction not visualized\", \"Temporal ordering of CK2 vs. DNA-PK phosphorylation events unclear\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Discovery that SUMOylation at K210 is required for XRCC4 nuclear localization, that ligase IV also controls XRCC4 import, and that XLF is a new XRCC4-interacting NHEJ factor expanded the regulatory and compositional complexity of the NHEJ ligation complex.\",\n      \"evidence\": \"In vivo SUMOylation assay with K210R mutagenesis and subcellular fractionation; co-IP and siRNA of XLF; direct Ku70–XRCC4 interaction by live-cell imaging\",\n      \"pmids\": [\"16478998\", \"16439205\", \"17124166\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SUMOylation is damage-regulated unknown\", \"Structural basis of XLF–XRCC4 interaction not yet determined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showing that XRCC4–ligase IV can ligate fully incompatible DNA ends and contributes to class switch recombination in B cells defined the remarkably flexible substrate scope and broader immune function of the complex.\",\n      \"evidence\": \"In vitro ligation with defined incompatible substrates; B-cell-specific conditional XRCC4 knockout mouse with CSR assay\",\n      \"pmids\": [\"17290226\", \"17606631\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How the complex accommodates mismatched ends structurally unknown\", \"Relative contribution of XRCC4/NHEJ vs. alternative end joining in CSR debated\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"A higher-resolution XRCC4–ligase IV BRCT structure revealed that BRCT2 makes essential contacts, refining the interface beyond the inter-BRCT linker model.\",\n      \"evidence\": \"X-ray crystallography with cellular complementation and dominant-negative overexpression\",\n      \"pmids\": [\"19332554\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length ligase IV–XRCC4 structure lacking\", \"How Ku docking alters the interface unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Crystal structures of XRCC4–XLF filaments revealed alternating head-to-head interactions forming a super-helical DNA-binding channel, establishing a structural paradigm for how NHEJ factors bridge and align broken ends.\",\n      \"evidence\": \"X-ray crystallography, SAXS, EM, site-directed mutagenesis, and isothermal titration calorimetry from two independent groups\",\n      \"pmids\": [\"21775435\", \"21768349\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether filaments form in vivo at physiological concentrations unknown\", \"How filament assembly is regulated by phosphorylation not determined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identification of FBXW7-mediated K63-polyubiquitylation of XRCC4 at K296 (triggered by DNA-PKcs phosphorylation of S325/326 and ATM phosphorylation of FBXW7) enhancing Ku association, together with APLF FHA recognition of phospho-XRCC4, revealed a multi-layered PTM code on XRCC4 that fine-tunes NHEJ complex assembly.\",\n      \"evidence\": \"Mass spectrometry, ubiquitylation assays, mutagenesis, clonogenic survival; crystal structure of phospho-XRCC4–APLF FHA complex\",\n      \"pmids\": [\"26774286\", \"26519825\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether K63-Ub serves as a platform for additional factor recruitment unknown\", \"Interplay between SUMOylation, ubiquitylation, and phosphorylation not integrated\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Single-molecule visualization of XRCC4–XLF complexes sliding along DNA and bridging two DNA molecules provided direct biophysical evidence for the mobile-sleeve model of end synapsis.\",\n      \"evidence\": \"Dual- and quadruple-trap optical tweezers with fluorescence microscopy\",\n      \"pmids\": [\"27437582\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Behavior in the context of chromatin and full NHEJ machinery not examined\", \"How sliding converts to stable synapsis for ligation unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Phospho-mimicking mutations in XRCC4/XLF C-terminal tails selectively ablated DNA bridging without affecting ligase IV stimulation, demonstrating that DNA-PK/ATM phosphorylation separates the bridging and ligation-support functions; structural characterization of the PNKP–XRCC4–LigIV ternary complex by SAXS/HDX-MS defined multi-point contacts enabling coupled end-processing.\",\n      \"evidence\": \"Systematic mutagenesis of 14 phospho-sites with separation-of-function assays; SAXS, HDX-MS, and reconstitution of ternary complex\",\n      \"pmids\": [\"28500754\", \"28453785\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the kinase(s) responsible for each site in vivo not fully resolved\", \"Cryo-EM or crystal structure of full synaptic complex lacking\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"The finding that RIG-I competes with LIG4/XLF for XRCC4 binding, suppressing NHEJ while XRCC4 reciprocally enhances RIG-I innate immune signaling, revealed an unexpected crosstalk between DNA repair and antiviral immunity.\",\n      \"evidence\": \"Co-IP, DSB recruitment assay, in vitro ligation, RNA virus replication assay, mouse model\",\n      \"pmids\": [\"33846346\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological contexts where this competition is dominant unknown\", \"Whether RIG-I interaction is direct or mediated by RNA/DNA intermediates not fully resolved\", \"Independent replication needed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A high-resolution structure of the complete NHEJ synaptic complex — XRCC4–ligase IV–XLF filament assembled on DNA ends with Ku and DNA-PKcs — has not been determined, leaving the architecture of end synapsis and the mechanism by which phosphorylation-induced filament disassembly triggers ligation unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No cryo-EM or crystal structure of the full synaptic complex\", \"Temporal sequence of PTM events during a single repair event not mapped in real time\", \"Whether XRCC4–XLF filaments form on chromatin substrates in vivo remains undemonstrated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [1, 16, 37]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [8, 30, 38]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [9, 13, 30, 31]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 18, 29, 32]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [17]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [0, 1, 10, 11, 16, 35, 38, 39]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 23]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 23]}\n    ],\n    \"complexes\": [\n      \"XRCC4–DNA ligase IV\",\n      \"XRCC4–XLF filament\",\n      \"XRCC4–ligase IV–PNKP\",\n      \"Ku–XRCC4–ligase IV\"\n    ],\n    \"partners\": [\n      \"LIG4\",\n      \"XLF\",\n      \"XRCC5\",\n      \"XRCC6\",\n      \"PNKP\",\n      \"APLF\",\n      \"FBXW7\",\n      \"PRKDC\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}